Latest / New Retina Radio by Eyetube
AAO 2021 Late Breakers: GATHER1 and ALTISSIMO
Knowing at which point in the course of disease progression a drug for geographic atrophy could be most effective may be key to unlocking a treatment paradigm if a drug is approved. What late-breaking data presented at the 2021 AAO annual meeting could help inform retina’s eventual strategy to treat GA?
New Retina Radio spoke with David Lally, MD, about his presentation on a post hoc analysis of the GATHER1 study to learn more about how GA patients who received avacincaptad pegol (Zimura, IVERIC bio) progressed from nascent disease to more advanced disease.
We also heard from Veeral Sheth…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.